Ventyx Biosciences (VTYX) Insider Trading & Ownership $2.02 +0.13 (+6.88%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Ventyx Biosciences (NASDAQ:VTYX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.18%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.26 MNumber OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$119,371.90 Get VTYX Insider Trade Alerts Want to know when executives and insiders are buying or selling Ventyx Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VTYX Insider Buying and Selling by Quarter Ventyx Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/27/2024John NussInsiderSell21,119$2.36$49,840.84 12/23/2024Sheila GujrathiDirectorBuy130,000$2.31$300,300.00 12/19/2024John NussInsiderSell13,161$2.26$29,743.86 11/25/2024Raju MohanCEOBuy261,752$2.01$526,121.52 11/22/2024Raju MohanCEOBuy238,248$1.83$435,993.84 4/2/2024Christopher W KruegerInsiderSell1,651$5.40$8,915.40 4/2/2024Martin AusterCFOSell1,405$5.40$7,587.00 4/2/2024Raju MohanCEOSell4,312$5.40$23,284.80 (Data available from 1/1/2013 forward) VTYX Insider Trading Activity - Frequently Asked Questions Who is on Ventyx Biosciences's Insider Roster? The list of insiders at Ventyx Biosciences includes Christopher W Krueger, John Nuss, Martin Auster, Nsv Partners Iii Lp, Raju Mohan, Sheila Gujrathi, Somu Subramaniam, William J Sandborn, and William Richard White. Learn more on insiders at VTYX. What percentage of Ventyx Biosciences stock is owned by insiders? 18.18% of Ventyx Biosciences stock is owned by insiders. Learn more on VTYX's insider holdings. Which Ventyx Biosciences insiders have been buying company stock? The following insiders have purchased VTYX shares in the last 24 months: Raju Mohan ($962,115.36), and Sheila Gujrathi ($300,300.00). How much insider buying is happening at Ventyx Biosciences? Insiders have purchased a total of 630,000 VTYX shares in the last 24 months for a total of $1,262,415.36 bought. Which Ventyx Biosciences insiders have been selling company stock? The following insiders have sold VTYX shares in the last 24 months: Christopher W Krueger ($1,467,215.40), John Nuss ($1,650,956.06), Martin Auster ($3,914,707.00), Nsv Partners Iii Lp ($15,048,842.20), Raju Mohan ($6,050,141.85), Sheila Gujrathi ($3,373,000.00), Somu Subramaniam ($9,003,942.13), William J Sandborn ($2,319,365.72), and William Richard White ($1,170,690.30). How much insider selling is happening at Ventyx Biosciences? Insiders have sold a total of 1,360,683 Ventyx Biosciences shares in the last 24 months for a total of $43,998,860.66 sold. Ventyx Biosciences Key ExecutivesDr. Sheila K. Gujrathi M.D. (Age 54)Executive Chairperson Compensation: $125kDr. Raju S. Mohan Ph.D. (Age 66)Founder, CEO, President & Director Compensation: $905.29kDr. John M. Nuss Ph.D. (Age 65)Chief Scientific Officer Compensation: $630.63kMr. Roy M. Gonzales CPA (Age 49)M.B.A., Interim Principal Financial Officer & Principal Accounting Officer Mr. Matthew Richard Moore (Age 51)Chief Operating Officer Dr. Mark S. Forman M.D. (Age 58)Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Humacyte Insider Trading CARGO Therapeutics Insider Trading Annexon Insider Trading Keros Therapeutics Insider Trading Mereo BioPharma Group Insider Trading Rapport Therapeutics Insider Trading Ginkgo Bioworks Insider Trading Entrada Therapeutics Insider Trading Tourmaline Bio Insider Trading Xeris Biopharma Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:VTYX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
